NEUROSTRUCTURES, INC. expands Patent Portfolio with Pylon™ Expandable Interbody Spacer

May 6, 2022 – OrthoSpineNews –

NeuroStructures, Inc. a medical device technology company focused on innovative development of spinal implants, announced it received Issue Notification from the U.S. Patent and Trademark Office (USPTO) Patent No. 11,304,817 on April 19, 2022, for an “Expandable Interbody Spacer”. 

This Expanding Solution represents the next generation of expandable technology.  The Pylon™ Expandable Interbody Spacer offers surgeons a modern approach with its Expandable PLIF / TLIF System.  With Streamlined Instrumentation, it provides the surgeon minimal tissue disruption and nerve retraction while restoring patient alignment.  Pylon™ cages are inserted at a Reduced Height to minimize impaction and Preserve Endplate integrity.  With Controlled and Continuous In Situ Expansion, Pylon™ allows for Foraminal & Disc Height Restoration.  Pylon™ Streamlines the Surgical procedure with Automatic Locking once Desired Expansion Height is achieved, without loss of Height Restoration.

Advertisement

Adjustable Trials reduces Trailing Steps and Accurately determines Optimal Implant and Disc Height, further streamlining the procedure.  Providing Multiple Footprints with Effective Sizing allows for Minimally Invasive Surgery (MIS) approach, and Optimal Fit for all patient anatomies.

As CEO, Eric Hansen is proud of this milestone and excited to offer this Expanding Technology to surgeons.  Hansen remains devoted to continuing his legacy of a “Company built by Surgeons for Surgeons.”  NeuroStructures as a company will endeavor to serve the spinal industry by providing comprehensive medical solutions to improve and enhance the quality of life for patients through innovation, cost cutting measures, and increased efficiencies.

For more information, please contact:
Eric Hansen 972-740-5181
Eric@InciteInnovations.com

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement